Skip to main content
PharmaCielo Ltd. logo

PharmaCielo Ltd. — Investor Relations & Filings

Ticker · PCLO ISIN · CA71716K1012 LEI · 5493002XOFWMT83TYQ57 TSXV Manufacturing
Open in API
Filings indexed 389 across all filing types
Latest filing 2021-04-01 Regulatory Filings
Country CA Canada
Listing TSXV PCLO

About PharmaCielo Ltd.

https://www.pharmacielo.com/

PharmaCielo Ltd. is a global supplier specializing in the cultivation, processing, and distribution of medicinal-grade cannabis extracts and dried flower. The company focuses on ethical and sustainable production, aiming to be a leading partner in the global medicinal cannabis market. Utilizing ideal equatorial conditions, PharmaCielo operates large-scale, high-efficiency production facilities, including 12 hectares of open-air greenhouses, enabling four full crops annually for reliable supply. Its product portfolio includes standardized extracts, such as high-purity CBD Isolate, and both psychoactive and non-psychoactive derivatives. Production adheres to pharmaceutical-quality standards, supported by proprietary genetics maintained in a tissue culture lab and advanced processing facilities ensuring consistency and safety.

Recent filings

Filing Released Lang Actions
Non-issuer's submission to jurisdiction and appointment of agent.PDF
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix C to National Instrument 41-101' and is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process.' It contains legal and procedural information related to jurisdiction and appointment of an agent for service of process, including names, addresses, and legal commitments. There is no financial data, no report of financial performance, no management discussion, no earnings information, no voting results, no capital changes, and no audit or regulatory certification. The document is a legal filing related to regulatory compliance and jurisdictional appointment rather than a financial or corporate report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or any financial report. It is best classified under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2021-04-01 English
Non-issuer's submission to jurisdiction and appointment of agent.PDF
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix C to National Instrument 41-101' and is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process.' It contains legal and procedural information about jurisdiction and appointment of an agent for service of process related to securities distribution under a prospectus. There are no financial statements, management discussion, earnings data, or other typical financial report content. The document is a regulatory filing related to legal and procedural compliance rather than a financial report or announcement. It is also relatively short (3512 characters) and does not contain any report or announcement of financial results or corporate actions. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2021-04-01 English
Auditors' consent letter.PDF
Regulatory Filings Classification · 95% confidence The document is a letter from an independent auditor providing consent for the use of their audit report in a short form prospectus related to a share offering. It references the auditor's report dated April 23, 2020, on financial statements for years ended December 31, 2019 and 2018. The letter states compliance with standards for auditor's consent in an offering document and explicitly mentions it is not an audit or review of the prospectus itself. The document length is short (2006 characters) and it is clearly an auditor's consent letter related to a financing prospectus, not the full audit report or the prospectus itself. This fits the category of a Regulatory Filing (RNS) as it is a regulatory compliance document and not a full audit report or financial report. Therefore, the correct classification is Regulatory Filings (RNS).
2021-04-01 English
Non-issuer's submission to jurisdiction and appointment of agent.PDF
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix C to National Instrument 41-101' and is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process.' It contains legal and jurisdictional information related to the appointment of an agent for service of process and submission to jurisdiction for securities distribution under a prospectus. There are no financial statements, management discussion, earnings data, or other typical financial report content. The document is a legal filing related to regulatory compliance rather than a financial report or announcement. It is also relatively short (3516 characters) and does not present financial data or results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2021-04-01 English
Non-issuer's submission to jurisdiction and appointment of agent.PDF
Regulatory Filings Classification · 100% confidence The document is titled 'Appendix C to National Instrument 41-101' and is a 'Non-Issuer Form of Submission to Jurisdiction and Appointment of Agent for Service of Process.' It contains legal and procedural information related to jurisdiction and appointment of an agent for service of process, including signatures and acceptance of appointment. There are no financial statements, earnings data, management discussion, or report content. The document is short (3505 characters) and appears to be a regulatory filing related to legal procedural compliance rather than a financial report or announcement. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is best classified under Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory or compliance documents that do not fit other categories.
2021-04-01 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a corporate update press release from PharmaCielo Ltd. It discusses a forthcoming equity financing offering, restatement and refiling of Q3 2020 financial statements and MD&A, updates to business outlook, downstream and upstream operations, and sales pipeline. The document includes detailed financial and operational updates but is primarily an announcement of ongoing financing and operational status rather than a full financial report. It references the restated Q3 2020 financial statements and MD&A but does not itself contain comprehensive financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). The document is lengthy (15,000 characters) and contains substantive information, but it is structured as a corporate update and financing announcement rather than a formal financial report. The focus on the overnight marketed equity financing and related details aligns with a Capital/Financing Update (CAP). Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-03-31 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.